GSK3B and gastric cancer: However, CLEC-2 has been shown to exert tumor-suppressive effects in gastric cancer by inhibiting signaling pathways such as AKT and glycogen synthase kinase-3 beta, thereby reducing tumor invasiveness 10,11.